Lesson plan
NESS-0327
NESS-0327 is a drug used in scientific research which acts as an extremely potent and selective antagonist of the cannabinoid receptor CB 1 . It is much more potent an antagonist, and more selective for the CB 1 receptor over CB 2 , than the more commonly used ligand rimonabant, with a K i at CB 1 of 350fM (i.e. 0.00035nM) and a selectivity of over 60,000x for CB 1 over CB 2 . Independently, two other groups have described only modest nanomolar CB 1 affinity for this compound (125nM and 18.4nM ). Also unlike rimonabant, NESS-0327 does not appear to act as an inverse agonist at higher doses, instead being a purely neutral antagonist which blocks the CB 1 receptor but does not produce any physiological effect of its own.
Article summary
NESS-0327 is a drug used in scientific research which acts as an extremely potent and selective antagonist of the cannabinoid receptor CB 1 . It is much more potent an antagonist, and more selective for the CB 1 receptor over CB 2 , than the more commonly used ligand rimonabant, with a K i at CB 1 of 350fM (i.e. 0.00035nM) and a selectivity of over 60,000x for CB 1 over CB 2 . Independently, two other groups have described only modest nanomolar CB 1 affinity for this compound (125nM and 18.4nM ). Also unlike rimonabant, NESS-0327 does not appear to act as an inverse agonist at higher doses, instead being a purely neutral antagonist which blocks the CB 1 receptor but does not produce any physiological effect of its own.
Key claims
No claims recorded.
Discussion questions
- Summarise the article in your own words. Which single claim would you verify first, and why?
- Which claim in this article is most likely to be revised as the sources update? How would you check its current status?
- If two sources disagreed about one of these facts, what would you need in order to trust one over the other?
Bibliography
No sources recorded.
Key claims and bibliography are generated from the same tracked claims and sources as the article page.